CONTACT
NAVARRA
+34 948 194 700
NAVARRA
×
INTRANET
PEOPLE FINDER
English
Español
WORK WITH US
INVESTOR AREA
/servlet/autocompletar/
Delete
DO YOU WANT TO HELP US?
ÚNETE A NUESTRO EQUIPO
ÁREA DE INVERSIÓN
About us
Universidad de Navarra Biomedical Campus
Research Center of the Clínica
Organization
Transparency Portal
Corporate Responsibility (Compliance)
Research
Diseases
Research divisions
Research groups
Technological platforms
Research and clinical trials
Research Staff
Human Resources Strategy for Researchers (HRS4R)
Scientific activity
Innovation
Pipeline
Patents
Entrepreneurship | Spin off
Collaboration with companies
Investor Area
Training
Cima Impulse
Training offer
Training contracts and grants
Collaborate with us
How to collaborate
Collaboration projects
Collaborating companies
Transparency
News
News
Events
Scientific Report 2024-25
Health and Science
Home
>
News
>
News
Cima Universidad de Navarra news
Specialties
Choose by department
Adhesion and Metastasis
Adoptive Cell Therapy
Adoptive Cellular Therapy
Advanced Therapies for Pediatric Solid Tumors
Advanced Therapies for Rare Liver Diseases
Animal Models
Animal Production and Experimentation
Applied and Translational Onco-Immunology
Aptámeros y Química Médica
Aptamers
Atherothrombosis
Biobank
Biochemical Analysis and Cell Metabolism
Bioinformatics
Biomedical Engineering
Cancer Division
Cancer gene therapy
Cardiac Tissue Engineering
Cardiovascular Diseases
Combination Strategies for Translational Immunotherapy
Computational Biology and Translational Genomics
Cytokine-Based Therapeutics
Cytometry
DNA and RNA Medicine
Dynamics of the antitumor immune response
Enable Technologies
Epigenetics
Epilepsy
Gene Therapy for Hereditary Hearing Loss and AAV Engineering
Gene Therapy for Monogenic Encephalopathies
Gene Therapy for Rare Diseases
Gene Therapy in Neurological Diseases
Gene Therapy in Neurological Disorders
Gene Therapy in Parkinson's Disease
Gene Therapy of Renal Diseases and Study of N-terminal Acetylation of Proteins
Genomics Unit
Heart Failure
Hemato-Oncology
Hepatology
Hepatology: Carcinogenesis and Liquid Biopsy
Hepatology: Metabolism, Epigenetics and Carcinogenesis
Hepatology: Molecular Mechanisms and Targets in liver carcinogenesis
Hepatology: Porphyrias and Carcinogenesis
Image
Immune Therapies
Immunology and Immunotherapy
Immunomodulation and Tumor Microenvironment
In vivo Organ Generation by Stem Cells
Locoregional Immunotherapy Strategies in Peritoneal Carcinomatosis
Lungsearch: Lung cancer Screening, Early detection, biomarkers and new therapeutic targets
Lymphomas
Machine Learning in Biomedicine
Medicinal Chemistry
Micro-PET
Microbiome and Clinical Physiology
Microphysiological Systems and Quantitative Biology
Morphology
Myelodysplastic Neoplasia
Myeloid Pathology
Neuroscience
Next Generation Gene Delivery Technologies
Non-coding RNA and Biotechnology
Noncoding RNA and cancer genome
Oncogenes and Effector Targets
Peptide
Physiological Control and Monitoring
Preclinical Models and Analysis Tools
Predictive Response Marker
Radioactive Facility
Radioimmunotherapy strategies for pediatric tumors
Regulación de la Expresión Génica
Renal Gene Therapy and Chimeric AAV Development
RNA and Senescence
RNA Biology and Therapy
Solid Tumor
Stress Responses and Liver Cancer Immunotherapy
Therapeutic Innovation
Therapeutic Innovation in Lung Cancer
Translational Hematology
Translational Immunomics in Hematological Neoplasms
Translational Oncology
Tumor Evasion and New Targets
Vaccine Development
Date from
Date to
Una nueva estrategia de inmunoterapia inyectada en tumores sólidos activa el sistema inmune evitando la toxicidad hepática
Los resultados de este estudio del Cancer Center Clínica Universidad de Navarra publicados en Clinical Cancer Research muestran los efectos de inyectar urelumab –anticuerpo monoclonal– directamente en el tumor en lugar de forma intravenosa
March 24, 2026
An experimental combination of radiation therapy and gene therapy is effective and safe for treating various types of cancer
Researchers at the Cancer Center Clínica Universidad de Navarra plan to begin the first patient trial in 2027 thanks to promising preclinical results from a gene therapy vector developed at CIMA that enhances radiation therapy in melanoma and pancreatic, colon, or lung cancer
March 23, 2026
No son raras, son poco frecuentes
El 28 de febrero se celebra el Día Mundial de las Enfermedades Raras
February 27, 2026
28 de febrero, Día Mundial de las Enfermedades Raras o Poco Frecuentes
“La colaboración es fundamental para que podamos avanzar en un abordaje integral de las enfermedades raras”
Pacientes, especialistas e investigadores se reúnen en el Cima Universidad de Navarra para compartir experiencias en torno a las enfermedades poco frecuentes
February 27, 2026
Identifican dos proteínas que controlan el crecimiento del cáncer de hígado pediátrico más frecuente
Un grupo del Cima participa en una investigación que abre la puerta a desarrollar nuevos tratamientos para los pacientes que no responden a las terapias
February 25, 2026
Immunological profile identified that predicts risk of infection in multiple myeloma
The results of this study by Cima Universidad de Navarra will enable more personalised medicine that identifies the most vulnerable patients at an early stage
February 24, 2026
